The US-based biopharmaceutical industry has dismissed the Biden administration's latest plan for the reform of prescription medicine pricing that does not include of form international reference pricing. …
International reference pricing not included in list of new US reforms
September 13, 2021 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Daily updates on COVID-19 vaccine - 24 September 2021
September 24, 2021 - - COVID-19 -
TGA rushes out another iteration of the COVID-19 advertising authorisation
September 24, 2021 - - Latest News -
Lockdown-driven delay hardly cuts it for PHARMAC review
September 24, 2021 - - Latest News -
Repurposing treatments for COVID-19 is not so simple
September 24, 2021 - - Latest News -
Amgen mandates COVID-19 vaccine for in-field staff
September 24, 2021 - - Latest News -
Sanofi marks 30 years of humanitarian program
September 24, 2021 - - Latest News -
AstraZeneca welcomes expanded approval for Forxiga
September 24, 2021 - - Latest News